David C. Myles, CH. DISCOV. & NON-CLIN Development Officer at Olema Pharmaceuticals, Inc. (OLMA), sold 200 shares at $17.61 ($4K) on 2023-11-08, disclosed to the SEC on 2023-11-13.
Scheduled sale ($4k) by CH. DISCOV. & NON-CLIN Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| OLMA | SELL | 2024-12-11 | $467K | — | Filing → |
| OLMA | SELL | 2023-11-22 | $389K | — | Filing → |
| OLMA | SELL | 2023-11-03 | $312K | — | Filing → |